Perrigo (PRGO)
(Real Time Quote from BATS)
$31.38 USD
+0.15 (0.48%)
Updated Apr 25, 2024 11:00 AM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Company Summary
Dublin, Ireland-based Perrigo Company plc was formed following the December 2013 merger of Allegan, MI-based Perrigo Company with Elan Corporation. The merged entity, with a diversified revenue stream, has a presence in the over-the-counter (OTC) market and wellness solutions designed to enhance individual well-being. Currently, the company's reporting segments are:
Consumer Self Care Americas (CSCA) – The segment comprises the U.S. and Canada consumer self-care business, including OTC, contract manufacturing, infant formula and oral care categories. The segment accounted for approximately 63.6% of the company’s total revenues in 2023.
<...
Company Summary
Dublin, Ireland-based Perrigo Company plc was formed following the December 2013 merger of Allegan, MI-based Perrigo Company with Elan Corporation. The merged entity, with a diversified revenue stream, has a presence in the over-the-counter (OTC) market and wellness solutions designed to enhance individual well-being. Currently, the company's reporting segments are:
Consumer Self Care Americas (CSCA) – The segment comprises the U.S. and Canada consumer self-care business, including OTC, contract manufacturing, infant formula and oral care categories. The segment accounted for approximately 63.6% of the company’s total revenues in 2023.
Consumer Self Care International (CSCI) – The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company’s consumer-focused businesses in the UK and Australia. This segment includes the U.K. liquids licensed products business. The segment accounted for 36.4% of total revenues in 2023.
Perrigo is focusing on self-care products as part of its transformation from a healthcare company into a self-care company. The company completed its transformation to a consumer self-care company in July 2021 by reconfiguring the portfolio through the divestiture of its generic prescription pharmaceuticals and diagnostic businesses (RX business) to Altaris Capital Partners for $1.55 billion.
In April 2022, Perrigo completed the acquisition of Héra SAS (“HRA Pharma"), a France-based leading global consumer self-care company, for €1.8 billion (or approximately $1.9 billion) in cash. The acquisition has added many market-leading, high-growth OTC popular self-care brands like Compeed and Mederma in skin care as well as ellaOne in women's health. The acquisition has also added a new rare disease portfolio to the company’s existing line of products.
Perrigo generated revenues of $4.7 billion in 2023, up 4.6% year over year.
General Information
Perrigo Company plc
THE SHARP BUILDING HOGAN PLACE
DUBLIN, L2 49010
Phone: 353-1709-4000
Fax: 269-673-9128
Email: bradley.joseph@perrigo.com
Industry | Medical - Products |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Earnings Date | 5/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.24 |
Current Year EPS Consensus Estimate | 2.55 |
Estimated Long-Term EPS Growth Rate | NA |
Earnings Date | 5/7/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 31.23 |
52 Week High | 40.28 |
52 Week Low | 25.77 |
Beta | 0.64 |
20 Day Moving Average | 1,153,262.25 |
Target Price Consensus | 40.67 |
4 Week | -0.73 |
12 Week | -2.65 |
YTD | -2.95 |
4 Week | 2.73 |
12 Week | -6.99 |
YTD | -8.73 |
Shares Outstanding (millions) | 135.52 |
Market Capitalization (millions) | 4,232.16 |
Short Ratio | NA |
Last Split Date | 8/26/1993 |
Dividend Yield | 3.54% |
Annual Dividend | $1.10 |
Payout Ratio | 0.42 |
Change in Payout Ratio | 0.07 |
Last Dividend Payout / Amount | 3/7/2024 / $0.28 |
Fundamental Ratios
P/E (F1) | 12.25 |
Trailing 12 Months | 12.10 |
PEG Ratio | NA |
vs. Previous Year | 14.67% |
vs. Previous Quarter | 34.38% |
vs. Previous Year | 0.15% |
vs. Previous Quarter | 2.95% |
Price/Book | 0.89 |
Price/Cash Flow | 5.93 |
Price / Sales | 0.91 |
3/31/24 | NA |
12/31/23 | 7.34 |
9/30/23 | 6.98 |
3/31/24 | NA |
12/31/23 | 3.24 |
9/30/23 | 3.08 |
3/31/24 | NA |
12/31/23 | 1.79 |
9/30/23 | 2.74 |
3/31/24 | NA |
12/31/23 | 1.07 |
9/30/23 | 1.60 |
3/31/24 | NA |
12/31/23 | 7.56 |
9/30/23 | 7.22 |
3/31/24 | NA |
12/31/23 | -0.27 |
9/30/23 | 0.15 |
3/31/24 | NA |
12/31/23 | -0.18 |
9/30/23 | 0.68 |
3/31/24 | NA |
12/31/23 | 35.19 |
9/30/23 | 34.99 |
3/31/24 | NA |
12/31/23 | 2.56 |
9/30/23 | 2.60 |
3/31/24 | NA |
12/31/23 | 0.76 |
9/30/23 | 0.85 |
3/31/24 | NA |
12/31/23 | 43.24 |
9/30/23 | 46.08 |